Navigation Links
24th Annual EAU Congress highlights many new developments
Date:2/5/2009

The 24th Annual Congress of the European Association of Urology (EAU) will be held from 17 to 21 March 2009 in the Stockholm International Fairs (SE). The EAU aims to present the best of scientific results, lectures and educational courses; the scientific programme covers the whole range of the urological field. Chairman of the EAU Scientific Congress Office Professor Freddie Hamdy has identified several scientific highlights.

In Stockholm the EAU expects to welcome an estimated 10,000 delegates and 3,000 exhibitors.

According to Professor Hamdy highlights include, among other things, the State-of-the-art lecture 'Watchful waiting versus radical prostatectomy - an updated from the SPCG-4 trial' by Professor Lars Holmberg from Uppsala (SE), held from 8:15 to 8:35 hours on Friday, 20 March. "In 2005 the researchers reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. Now results after 3 more years of follow-up are reported", he says.

The lecture 'The PCA3 test in the diagnosis of prostate cancer' by Dr. Monique Roobol from Rotterdam (NL) Friday 20 March from 9:20 to 9:35 hours gives an overview of the value of the Prostate Cancer Antigen 3 (PCA3) test for clinical applications based on the available literature and new data. The serum PSA value is the most commonly used marker in the detection and monitoring of prostate cancer, but prostate cancer is present throughout the entire PSA spectrum; this was confirmed by the biopsy results in men randomised to the control arm of the Prostate Cancer Prevention Trial (PCPT). Developments in molecular biology techniques have led to the identification of numerous genes and proteins that are believed to be relevant for the development of prostate cancer. This has resulted in a commercially available gene-based test, the PCA3 test.

On the same day, from 10:05 to 10:25 hours, Dr. Martin Gleave will give the Socit Internationale d'Urologie lecture 'Castration resistant prostate cancer: New therapeutic approaches'. Advanced prostate cancer has high initial response rates to androgen ablation. However, remissions are temporary because surviving tumour cells usually progress to castrate-refractory prostate cancer. Dr. Gleave will be discussing the status of several novel agents in clinical trials either as single agents or in combination with cytotoxic chemotherapy, including the androgen receptor, endothelin receptor, and molecular chaperones.

Dr. Smith from Boston (U.S.) is keen on presenting the exciting results of his trial (A randomized, double-blind, placebo-controlled trial of denosumab in men receiving androgen deprivation therapy for non-metastatic prostate cancer) from 10:25 to 10:55 hours as part of the 'The best EAU papers' session.

According to Dr. Johann de Bono from London (UK), who will be presenting 'New approaches to target androgen receptors in prostate cancer' from 11:45 to 12:00 hours, there is now incontrovertible evidence that what we have previously defined as hormone refractory prostate cancer is a disease that remains steroid hormone drive. Clinical evidence is now available that novel agents targeting androgen synthesis and more potent androgen receptor antagonists have significant antitumor activity. He will be reporting about trials with these novel agents.

On Saturday, 21 March, Professor Fritz Schrder from Rotterdam (NL) will be giving an important update on the European Randomised Study of Screening for Prostate Cancer (ERSPC) from 11:15 to 11:35 hours. The ERSPC is a large European study involving 8 countries (Belgium, Finland, France, Italy, Sweden, Spain, Switzerland and the Netherlands). This presentation will, for the first time, summarise results obtained by all centres.

More information about the new initiative 'EAU TV', the Meet-the-Expert sessions and the EAU Press Conference which will be opened by Swedish TV host and producer Mr Hasse Aro - will follow shortly.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
31-263-890-680
European Association of Urology
Source:Eurekalert

Related medicine news :

1. Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party
2. AUA Annual Scientific Meeting features more new research than ever before
3. Healthy Humor & Laughter are in the Cards at the 22nd Annual Association for Applied and Therapeutic Humor Conference
4. GBC Seeks Nominations for Fourth Annual Bioscience Awards
5. Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C.
6. Cadient Interactives Will Reese to Discuss Strategies for Engaging Physicians Online at Eighth Annual ePharma Summit
7. Align Technology Executives to Present at ROTH 21st Annual OC Growth Stock Conference
8. Elder Abuse Prevention the Focus of Wayne County Medical Society Foundations Annual Chinese New Year Fundraiser
9. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
10. Michigan Dentists Giving Free Dental Care to Low-Income Children During Annual Give Kids a Smile Program Starting February 6
11. Sunstar to Support ADAs 60th Annual National Childrens Dental Health Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
(Date:2/24/2017)... ... 2017 , ... An in-depth computational analysis of genetic variants implicated in both ... genes that may explain why susceptibility to one of the disorders could place individuals ... today in the journal npj Schizophrenia. , “There is a wealth of genomic ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only ... jobs in the United States may be taken over by technology in the next ... who steamrolls over colleagues is drawing to a close. Success will belong to those ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... disabilities, it is so critically important that we all are aware of our ... why Mediaplanet is proud to announce the launch of its newest edition of ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... BRISBANE, Australia , Feb. 23, 2017  Directors from Pharma ... the two companies have joined forces, resulting in the founding of ... . Pharma To Market are pleased to announce their ... an office in Singapore . The company are ... Consulting as Co-Director of the Singapore based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Februar 2017 LG Innotek hat heute die ... Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... zwischen 200 und 280 nm und eignet sich damit für ... ihre DNA zerstört. Das Produkt von LG Innotek erzeugt ... ...
Breaking Medicine Technology: